Professor
Rutgers University School of Dental Medicine
Maplewood, New Jersey, United States
Dr. Paul J. Desjardins is a dentist and clinical pharmacologist with 40 years of leadership experience in academic institutions, the pharmaceutical industry and in the drug and device development industries. He is the principal scientist and President of Desjardins Associates, LLC. He is an Adjunct Professor at Rutgers School of Dental Medicine and at Tufts University School of Dental Medicine. Dr. Desjardins has consulted with over 50 large and small pharmaceutical companies since 2011.
Dr. Desjardins received his BS with honors in Pharmacology and Toxicology from the University of Rhode Island, DMD from Tufts University School of Dental Medicine and his Ph.D. in Pharmacology from Georgetown University. He completed a 2 year hospital-based residency in Rochester, NY. From 1981 to 1998, Dr. Desjardins he served as Professor of Oral Surgery and Oral Biology and Associate Dean for Academic Affairs at UNMNJ (now Rutgers).
From 1998 to 2005, Dr. Desjardins served as Executive Vice President at SCIREX Corporation and from 2005 - 2011, he served as Sr Vice-President, Global Clinical and Medical Affairs for Pfizer Consumer Healthcare (PCH) in Madison NJ.
Disclosure(s): Eli Lilly: Consultant (Ongoing); Haleon: Board Member/Advisory Panel (Ongoing), Consultant (Ongoing); Kenvue Brands: Board Member/Advisory Panel (Ongoing), Consultant (Ongoing); Maxona Pharmaceuticals: Board Member/Advisory Panel (Ongoing), Consultant (Ongoing)
(6518) Lunch Symposium: Nonopioid Alternatives to Opioids to Manage Dental Pain
Friday, October 24, 2025
11:30 AM - 1:15 PM ET